ORs (95% CIs) for 30-day death/stroke for CEA versus CAS in EVA-3S, SPACE, ICSS and CREST*
| Trial | OR (95% CI) |
| EVA-3S8 | 0.38 (0.16 to 0.84) |
| SPACE9 | 0.89 (0.55 to 1.42) |
| ICSS11 | 0.53 (0.35 to 0.80) |
| CREST*18 | 0.52 (0.29 to 0.92) |
| Meta-analysis | 0.59 (0.42 to 0.81) |
*Only symptomatic patients from CREST were included.
CAS, carotid artery stenting; CEA, carotid endarterectomy; CREST, Carotid Revascularisation versus Stenting Trial; EVA-3S, Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis; SPACE, Stent-Protected Angioplasty versus Carotid Endarterectomy.